deepull appoints Didier Deltort to its Board of Directors
Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, today announces the appointment of Didier Deltort to its Board of Directors.
- Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, today announces the appointment of Didier Deltort to its Board of Directors.
- Didier has spent over 30 years leading healthcare technology innovation and businesses around the world.
- Prior to Zimmer Biomet, Didier was Senior Vice President and General Manager, Global Healthcare Solutions and Partnerships at Boston Scientific.
- I look forward to working closely with the Management and the Board as deepull heads towards important clinical and commercial milestones.”